| mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
QL-XII-47 |
GDSC1000 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |